The image-guided radiation therapy (IGRT) market is experiencing significant growth driven by continuous advancements in imaging technologies. One of the key methods emerging is the integration of advanced imaging techniques such as Cone Beam Computed Tomography (CBCT) and Magnetic Resonance Imaging (MRI) into radiation therapy systems. These allow real-time imaging during treatment, enhancing precision and minimizing damage to surrounding healthy tissues.
In addition, there is a growing use of artificial intelligence (AI) and machine learning (ML) to analyze imaging data. AI assists in automating the process of image registration and alignment, improving efficiency and reducing human error. The introduction of adaptive radiotherapy (ART) systems, which dynamically adjust the treatment plan based on daily imaging feedback, is also contributing to market growth.
Furthermore, the development of hybrid imaging technologies that combine multiple modalities, such as MRI with PET or CT scans, provides superior soft tissue visualization, essential for complex tumor targeting. As these technologies evolve, IGRT is increasingly seen as essential in treating cancers with high precision, leading to the market's expansion in both developed and emerging regions.
